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Summary 
To investigate the role of the receptor-type tyrosine 
kinase, c-kif and its ligand, stem cell factor (SCF) in 
T cell development, we analyzed c-kit (W/W) and SCF 
(SIISI) deficient mice. We also engrafted wild-type or 
SCF-deficient fetal thymi onto wild-type recipient mice 
and analyzed the rate of proliferation by in vivo bro- 
modeoxyuridine labeling. The results show that the 
most immature thymocyte compartment defined as 
CD3-CD4-CDB- is significantly reduced in SVSI grafts 
and W/W thymi compared with wild-typecounterparts. 
Also, the expansion rate of these immature thymo- 
cytes in SllSl graft is reduced by - 50%. These experi- 
ments provide direct evidence for an important role 
for c-kit-SCF interactions in expansion of very early 
thymocytes. 
Introduction 
Mice bearing spontaneous mutations at the dominant 
white spotting (W) or steel (SI) loci exhibit similar develop- 
mental abnormalities in several cell lineages, including 
melanocytes, germ cells, and hematopoietic stem cells 
(HSC), causing cutaneous white spots, sterility, and ane- 
mia, respectively. Transplantation experiments estab- 
lished that W mutations are intrinsic to melanocytes, germ 
cells, and HSC, while SI mutants are defective in microen- 
vironments that support development of those cell lin- 
eages (reviewed by Russell, 1979). The W locus encodes 
the receptor-type tyrosine kinase c-kit (Chabot et al., 1988; 
Geissler et al., 1988). c-kit ligands have been identified 
as soluble or transmembrane forms of stem cell factor 
(SCF), which are products of the steel locus. W/W (lethal 
in early postnatal life) and SVSI (lethal in late gestation) 
mice bear deletions in c-kit and SCF genes, respectively, 
and thus lack expression of c-kit or SCF proteins (Ander- 
son et al., 1990; Copeland et al., 1990; Huang et al., 1990; 
Williams et al., 1990; Zsebo et al., 1990; Flanagan et al., 
1991; reviewed by Galli et al., 1994). 
HSC activity as revealed by multilineage developmental 
potential, long-term reconstitution, and spleen colony 
(CFU-S) formation are exclusively contained within the 
c-kif+, but not c-kit- cell population in bone marrow (Ogawa 
et al., 1991; lkuta and Weissman, 1992). In T lineage cells, 
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c-kit is expressed on pro-thymocytes isolated from fetal 
blood (Rodewald et al., 1994) and in subsets of very early 
fetal and adult intrathymic precursors (Godfrey et al., 
1992, 1993, 1994; Matsuzaki et al., 1993; Hozumi et al., 
1994). SCF transcripts are expressed, among other tis- 
sues, in thymic stromal cells (Zsebo et al., 1990; McNiece 
et al., 1991; Mall et al., 1992; Wiles et al., 1992; Williams 
et al., 1992; Moore et al., 1993). This expression pattern 
suggested a function for c-kit and SCF in thymocyte devel- 
opment. As discussed recently by Zlotnik and Moore 
(1995), however, sufficient data to clarify the potential role 
for this growth factor-ligand pair in T cell development 
was not available. 
In the present study, thymocyte development was ana- 
lyzed in both receptor (W/W) and ligand (SIISI) deficient 
mice, and in wild-type mice following grafting of SCF- 
deficient or wild-type fetal thymus. We show here that size 
of the most immature thymocyte compartment is reduced 
-40-fold in the W/W thymus and - 1Bfold in the SVSI 
thymus graft compared with wild-type levels. Moreover, 
bromodeoxyuridine (BrdU)-labeling experiments in vivo 
reveal that - 50% of the proliferation rate of very immature 
thymocytes is driven by intrathymically expressed SCF. 
These findings directly demonstrate an important role for 
SCF in the intrathymic expansion of recent thymic immi- 
grants. 
Results 
The Size of the Most Immature Thymocyte 
Compartment in W/W Mice Is Reduced -40-Fold 
WiW fetal mice differ from wild-type littermates by their 
hypocellular hematopoietic organs (Russell, 1979). This 
was confirmed by an - 1 O-fold reduction in total nucleated 
cell numbers in liver (2.4 x 10’ versus 0.29 x 10’) and 
spleen (3.6 x lo6 versus 0.35 x 106) comparing day 18 
fetal wild-type or W/W mice. Cellularity was also reduced 
in the thymus; however, wild-type and W/W mice differed 
only by a factor of two (5.1 x 1 O6 versus 2.5 x 1 06) (Table 
1). This difference in thymic cellularity remained constant 
throughout peri- and postnatal life. Thymocyte subsets 
were analyzed phenotypically from 2-day-old W/W and 
wild-type littermates. The four major populations (CD4%D8- 
[double-negative], CD4+CD8+ [double-positive], CD4+CD8- 
[single-positive], and CD4XD8+ [single-positive]) were pres- 
ent in both wild-type and W/W thymi (Figure 1, left) with 
comparable percentages of double-positive (DP) and sin- 
gle-positive (SP) subsets. Indicative of normal mature thy- 
mocytes, T cell receptor expression levels were high on 
SP thymocytes from both wild-type and WiW mice (data 
not shown). These results demonstrate that c-kit is not 
required for the generation of DP and mature SP thymo- 
cytes. 
In contrast with these mature stages of intrathymic de- 
velopment, there was an -4-fold reduction in the percent- 
age of double-negative (DN) thymocytes in W/W (3.3%) 
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Table 1. Total Cellularity in Hematopoietic Organs in Day 18.5 Fetal Wild-Type and Homozygous White Spot (WIW) Mice 
Fetal liver (x 1 O-3 Fetal spleen (x 10-B) Fetal thymus (x lo-3 
Wild type’ WiW* Ratio (W/wt) Wild type W/W Ratio (W/wt) Wild type w/w Ratio (W/v&) 
23.8b f 4.4 2.9 f 0.47 0.12 3.6 f 0.9 0.35 f 0.13 0.1 5.1 2 0.9 2.5 f 0.79 0.49 
(nc = 4) (n = 3) (n = 2) (n = 3) (n = 4) (n = 3) 
a Fetal mice were typed into wild-type or W/W phenotypes according to the color of skin and liver. Lack of c-kit expression on WMI fetal liver cells 
was verified by flow cytometrical analysis (data not shown). 
D Mean f SD. 
c Indicates number of individual fetal mice analyzed. 
compared with wild-type (12.3%) mice (Figure 1, left). 
Since DN thymocytes contain both early intrathymic 
(CD3) progenitors as well as mature DN a8 and ~6 cells, 
DN thymocytes were further analyzed for their composi- 
tion. Within the DN compartment, the earliest thymocytes 
(pre-V(D)JP chain rearrangement) express intermediate 
levels of Thy-l (Thy-lint) (Trowbridge et al., 1985) and are 
CD2-“O (Rodewald et al., 1993). Accordingly, the vast ma- 
jority of thymocytes from recombination-activating gene-2-j- 
(ffAGT’-) mice, in which thymocyte development is ar- 
wt 2 0 
w/w 2 0 
CD8 
RAG-2-I- 
Thy-i 
Figure 1. Phenotypic Analysis of Day 2 Postnatal Wild-Type and W/W 
Thymocytes Reveals a Severe Reduction in the Number of the Earliest 
Thymocytes in &t-Deficient Mice 
Thymocytes derived from P-day-old wild-type (wt) (top row) and W/W 
(middle row) mice were analyzed for expression of CD4 versus CD8 
(left), and 2-day-old wild-type, W/W, and adult RAG2-‘- (bottom row) 
for expression of Thy-i versus CD2 (right) by two-color flow cytometry. 
While the percentages of DN thymocytes are reduced -4-fold, the 
percentages of Thy-l’“‘CD2-” thymocytes are reduced -20-fold com- 
paring wild-type and W/W mice. As shown from the parallel analysis 
of the RAGP-‘- thymus, the Thy-1’n’CD2-f10 phenotype corresponds to 
the most immature thymocytes prior to V(D)Jg chain rearrangement 
(Rodewald et al., 1993). Total thymic cellularity was reduced by - 50% 
in W/W compared with wild-type thymus. Data are representative for 
four independent experiments. 
rested at the DN stage (Shinkai et al., 1992), are Thy-l’“’ 
CD2-“O (Figure 1, right, third row) (Rodewald et al., 1993). 
Interestingly, the percentage in this compartment was 
-20-fold reduced in W/W (0.8%) when compared with 
wild-type (11.7%) mice (Figure 1, right, first and second 
row). Considering total thymic cellularity, the size of the 
earliest thymocyte compartment is thus reduced -4O-fold 
in W/W compared with wild-type littermates. In contrast, 
DN CD3+ mature thymocytes were present in comparable 
numbers in both wild-type and W/W mice (data not shown). 
Analysis of Thymocyte Development in SI/SI or 
Wild-Type Thymi Grafted into Wild-Type 
Recipient Mice 
The significant reduction in the total number of the most 
immature DN thymocytes in W/W mice suggested an ef- 
fect of c-kit deficiency on prethymic or very early intra- 
thymic development stages, or both. To distinguish these 
possibilities, fetal day 14.5 C57BU6 (Ly5.1+) wild-type or 
SllSl thymi were grafted under the kidney capsules of con- 
genie recipient BELy5.2 (Ly5.2+) mice. Day 14.5 fetal SllSl 
mice showed only slightly reduced body weights, while 
thymic cellularity was reduced approximately lo-fold (Ta- 
ble 2), indicative of their severe hematopoietic defect (Rus- 
sell, 1979; Galli et al., 1994). Wild-type grafts showed a 
mean total cellularity of 6.7 x 1O’cells 3 weeks after trans- 
plantation, while SKI grafts contained approximately half 
that cell number (3.3 x lo7 cells) (Figure 2A). Of note, 
numbers of recent bone marrow-derived thymocytes were 
reduced - 5fold comparing SllSl(O.28 x 1 O6 cells) versus 
wild-type (1.8 x lo6 cells) grafts (Figure 28). At this time, 
cellularity in both types of grafts reached plateau levels, 
since cell numbers did not increase further at later time- 
points (data not shown). To determine whether grafts were 
colonized by host-derived tissue (i.e., fibroblasts, endothe- 
lial cells) that might express SCF, thymus transplants were 
analyzed for expression of SCF mRNA by rever8e poly 
merase chain reaction (PM) (Figure 2C). SCF mRNAwas, 
as expected, expressed in both the endogenous host thy- 
mus (Figure 2C, top, lane 1) and in the wild-type thymus 
graft (Figure 2C, top, lane 2). In contrast, even 10 weeks 
after transplantation the SIISI-derived graft lacked detect- 
able SCF mRNA (Figure 2C, top, lane 3). Hence, SI/SI 
grafts were not colonized by SCF-producing cells. 
To assess precursor differentiation in wild-type and 
SCF-deficient thymi, thymocytes were analyzed for ex- 
pression of Ly5.1 versus CD4 and CD8. Approximately 
70% of all thymocytes were of thymus graft origin and 
Table 2. Body Weight and Total Thymic Cellularity in Day 14.5 Fetal Wild-Type and SllSl Mice 
Body weight” 
Wild typeb SllSlb 
250” f 16 190 + 39 
(n” = 5) (n = 5) 
s Body weight in milligrams. 
Ratio (Sl/wt) 
0.76 
Total number of thymocytes per fetus (x lo-“) 
Wild typeb SVSI Ratio (Sl/wt) 
8.3 f 1.9 1.0 f 0.5 0.12 
(n = 4) (n = 5) 
b Fetal mice derived from timed-pregnant C57BU6 Sl/wt mice crossed to C57BU6 Sllwt males were typed into wild-type and SllSl according to 
the color of skin and liver. The absence of SCF in mRNA in SllSl fetal liver cells was verified by reverse PCR (see Experimental Procedures; data 
not shown). 
c Mean f SD. 
d Indicates number of individual fetal mice analyzed. 
A 
total thymcqtes 
,08 X-6.7~10~ 
+ 
lo5 L 
%=3.3x10 
+ 
wt 
C 
SllSl 
rn 
1234 
bp I 
k CD3-CD4-CD8- 0 #f bone marroworigin 
ji -1.6~10~ 
+ 
x-2.8x10’ 
-k 
Sl/Sl 
505-c\ -- I-SCFmRNA 
I 
- actin mRNA 
I 4 
Figure 2. Cellularity and the Expression of SCF in Wild-Type and SI/ 
SI Thymic Grafts 
-30% were host (bone marrow) derived 3 weeks after 
grafting of either wild-type (Figure 3A, top) or SllSl fetal 
thymus (Figure 3A, bottom). Both wild-type and SIISI- 
derived thymocytes generated comparable percentages 
of DP and SP thymocytes (Figure 38, top and bottom). In 
contrast, percentages of DN thymocytes of bone marrow 
origin were reduced -3-fold comparing Sl/Sl(3.1%) (Fig- 
ure 3C, bottom) and wild-type thymus (8.0%) (Figure 3C, 
top). Similar to the phenotype identified in the W/W thy- 
mus, the percentage of Thy-lint CD2-“0 was reduced - Sfold 
comparing SVSI (0.7%) and wild-type (4.6%) grafts (Fig- 
ure 3D). This reduction in the percentage of the most im- 
mature thymocyte subset was observed in five indepen- 
dent experiments comparing SKI and wild-type grafts, 
and remained constant at all timepoints analyzed (up to 
10 weeks after transplantation). Considering total thymic 
cellularity, the most immature thymocyte compartment is 
therefore - 12-fold smaller in SVSI compared with wild- 
type grafts. 
lntrathymic Expression of SCF Stimulates the 
Expansion of Recent Thymus Immigrants 
To analyze directly the role of SCF in the thymic environ- 
ment for the proliferation of the earliest thymic immigrants, 
BrdU labeling was performed in vivo. Recipient mice were 
injected with a single dose of 800 trg BrdU intraperitone- 
ally, a dosage previously shown not to affect thymocyte 
subset composition in vivo (Huesmann et al., 1991), 3 
weeks after transplantation of either wild-type or SVSI fetal 
thymus grafts. Since immature thymocytes are rapidly di- 
viding cells (Scollay et al., 1988) thymus grafts were re- 
moved after 4 hr. Subsequently, the percentagesof BrdU+ 
cells among total, or cell sorter-purified, CD3-CD4-CD8- 
bone marrow-derived (Ly5.2+) thymocytes was deter- 
mined by flow cytometry. One representative out of three 
(A-B) Thymic cellularity of wild-type and SIISI-derived grafts after 
transplantation into B6Ly5.2 congenic recipient mice. Wild-type 
C57BU6 (closed circles) and SVSI (open circles) grafts (both Ly5.1’) 
were removed from the kidney capsule of wild-type recipient B6Ly5.2 
mice (Ly5.2) 3 weeks after transplantation. Cell numbers were deter- 
mined for total thymocytes (A) and for bone marrow-derived 
Ly5.2CD3-CD4~CDE~ thymocytes (6) following flow cytometric analy 
sis for expression of Ly5.2, CD3, CD4, and CD8 for each graft. Each 
dot represents an individual graft. The crossbar indicates the mean 
value for each group of grafts. 
(C) SIISI-derived thymus grafts are not colonized by SCF expressing 
host-derived cells. Thymus grafts and endogenous thymus were re- 
moved from recipient mice 10 weeks after transplantation. Endoge- 
nous (lane 2) transplanted wild-type (lane 1) and transplanted SllSl 
(lane 3) thymi were analyzed by reverse PCR for the expression of 
either SCF mRNA (top, 505 bp fragment) or actin (bottom, 455 bp 
fragment). PCR products were probed by Southern blotting with SCF 
and actin-specific oligonucleotides independent from the amplimers. 
Both amplifications were specific as shown by omission of cDNA tem- 
plate (lane 4). 
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Figure 3. Analysis of Host (Bone Marrow) and Donor (Fetal Thymus) Contribution to Thymocyte Development in Wild-Type and Steel Mutant Grafts 
C57BU6 (Ly5.1) wild-type (top) or SVSI (bottom) thymi grafted under the kidney capsule of B6Ly5.2 recipient mice were analyzed by three-color 
flow cytofluorometry for the presence and development of thymusderived (Ly5.1’) and bone marrow-derived (Ly5.1.) thymocytes. Bone marrow- 
derived thymocytes were also positively identified as Ly5.2’ cells (data not shown). Two parameters are shown at a time: CD4 versus Ly5.1 (column 
A); CD4 versus CD6 gated on thymus-derived cells only (column B), CD4 versus CD6 gated on bone marrow-derived cells only (column C), and 
CD2 versus Thy-l for all thymocytes (column D). Cells (5 x 10’) were analyzed per sample gating on viable lymphocytes. Numbers given in the 
individual quadrants and gates indicate percentages. 
experiments is shown in Figure 4. Among total thymo- 
cytes, the fractions of BrdU+ cells were comparable be- 
tween wild-type and SllSl grafts (14.7% versus 13.3%) 
(Figure 4, left). In contrast, among bone marrow-derived 
immature thymocytes of the triple-negative (TN) pheno- 
type 23.8% had incorporated BrdU in the wild type, but 
only 11.8% in the SCF-deficient thymus graft (Figure 4, 
right). Hence, - 50% of the intrathymic proliferation rate 
of TN thymocytes is driven by the presence of SCF inside 
the thymic environment, while the remaining expansion 
at the TN stage appears to be c-kif/SCF independent. 
SCF mRNA (reviewed by Galli et al., 1994). The wild-type 
recipient mouse may provide, however, soluble SCF 
through the circulation to the graft. Nevertheless, several 
facts support the notion that membrane-bound SCF pro- 
motes hematopoiesis more efficiently than soluble SCF. 
Notably, another Steel mutant, Sld, lacks expression of 
membrane-bound, but not soluble, SCF (Brannan et al., 
1991; Flanagan et al., 1991). The facts that SP mice, al- 
though viable, display severe anemia, and SP spleen and 
bone marrow fail to support hematopoiesis of wild-type 
precursors, point to a critical role of membrane-bound SCF 
in hematopoiesis (Russell, 1979; Toksoz et al., 1992; Galli 
et al., 1994). 
The affected stage in T cell ontogeny (Thy-l’“’ CD2-“O) 
precedes T cell receptor V(D)Jp chain rearrangements 
(Trowbridge et al., 1985; Rodewald et al., 1993). A reduc- 
tion in cell number in this thymocyte compartment is con- 
sistent with the reported expression of c-kit in very early 
T cell precursors. In fetal ontogeny, c-kit is expressed on 
fetal blood pro-thymocytes defined as Thy-l+c-kit0 (re- 
viewed by Rodewald, 1995) on total day 13 fetal thymo- 
cytes (Godfrey et al., 1992) and on fetal intrathymic stem 
cells defined as Thy-l r°CD44+CD25- (Hozumi et al., 1994). 
Likewise, the earliest stage in the adult thymus, known 
as the CD4’O population (Wu et al., 199la, 1991 b), as well 
as their progeny, defined by the CD44+CD25+ phenotype, 
are c-kif+ (Antica et al., 1993; Godfrey et al., 1993). All of 
these c-kit+ populations lack T cell receptor V(D)Jp chain 
rearrangements (Wu et al., 1991 b; Godfrey et al., 1994; 
Hozumi et al., 1994). Collectively, these findings indicate 
that SCF-driven expansion acts on very early thymic immi- 
Discussion 
It is well established that SCF-c-kit interactions provide 
critical signals in erythropoiesis and myelopoiesis. In this 
study, we took advantage of mutant mice lacking c-kit or 
SCF to address the question whether SCF-c-kit interac- 
tions are involved in thymocyte development in vivo. Here, 
we find the same stage of thymocyte development to be 
affected in both the W/W thymus (Figure l), and in SKSI, 
but not wild-type, grafts (Figures 28 and 3D). While the 
phenotype in the W/W thymus may result from diminished 
stem cell supply or lack of SCF-c-kit interactions inside the 
thymus, or both, the grafting experiments directly reveal a 
role for intrathymically expressed SCF. SllSl mutant grafts 
express neither membrane-bound nor soluble SCF, and 
the mutant thymus is not colonized by host-derived SCF- 
producing cells (Figure 2C). This is noteworthy, since a 
variety of nonhematopoietic cell lineages such as fibro- 
blasts and vascular endothelial cells were found to express 
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Figure 4: SCF-Driven Thymocyte Expansion: Analysis of BrdU Incor- 
poration in Thymocytes Developing in Wild-Type or SCF-Deficient En- 
vironmonts 
Recipient mice (Ly5.2) were injected intraperitoneally with a single 
dose of 600 ug BrdU 3 weeks after transplantation of either wild-type 
(solid bars) or SllSl (stippled bars) grafts (Ly5.1). Grafts were removed 
from the kidney capsule 4 hr later and single cell suspensions of 
either total (left) or cell sorter-purified bone marrow-derived LyZXD3~ 
CD4-CD6- thymocytes (right) were analyzed for the percentage of 
BrdU’ cells by flow cytometry. Data shown are representative for three 
experiments. 
grants prior to productive T cell receptor p chain re- 
arrangements. 
In contrast with the effect on the most immature thymo- 
cyte pool, the absence of SCF causes a reduction in the 
overall thymic cellularity of only -50% (Figure 2), sug- 
gesting that lack of amplification at an early phase can 
be compensated at later stages of differentiation. This 
might be accomplished by an increased expansion or by 
an extended life-span at later stages. The rate of BrdU 
incorporation into total thymocytes, dominantly of the DP 
phenotype, was comparable between wild-type and SCF- 
deficient grafts (Figure 4), suggesting that cell numbers 
are “filled up” prior to the DP stage, but after productive 
V(D)Jp chain rearrangements at the DN stage. 
The observed mild hypocellularity in total cell numbers 
is in agreement with earlier experiments analyzing steel- 
deficient and wild-type thymi grafted onto wild-type mice 
for their cellularity and histological composition (Asamoto 
and Mandel, 1981). However, those experiments did not 
provide insights into the developmental stage at which the 
mutation exerts its effect. 
More recent studies on the role of SCF-c-kit in lympho- 
cyte development relied on suppressive effects of anti-c-kit 
antibodies in vivo and in vitro. Since infusion of antagonis- 
tic anti-c-kit antibodies inhibits most HSCs in vivo, such 
analyses could not distinguish whether the antibody di- 
rectly perturbs development of committed lymphocyte pro- 
genitors, or effects lymphocyte development only indi- 
rectly via its effects on HSCs (Ogawa et al., 1991). Several 
groups reported that anti c-kit monoclonal antibody (MAb) 
treatment partially blocked reconstitution of fetal thymic 
organ cultures (FTOC), suggesting a role for SCF-c-kit in 
thymocyte differentiation (Godfrey et al., 1992; Matsuzaki 
et al., 1993; Hozumi et al., 1994). However, these experi- 
ments did not provide evidence for clear phenotypic alter- 
ations of thymocyte subsets following MAb treatment. 
Nevertheless, the reduced recovery of thymocytes from 
antibody-treated FTOC is in agreement with the findings 
reported here from mutant mice lacking c-kit on progeni- 
tors or SCF in the thymic environment. 
Lack of melanocytes in skin, deficiency in mast cell lin- 
eages, and sterility in white spot and steel mutant mice 
are known to reflect, at least in part, the impaired migration 
of melanocyte, mast cell, or germ cell lineages during em- 
bryonic development. These precedents raised the possi- 
bility that membrane-bound or secreted SCF in the thymic 
environment facilitate the colonization of progenitor cells 
through adhesion, chemotaxis, or both. While our data 
do not rule out these possibilities, in vivo BrdU labeling 
experiments reveal an - 50% reduction in the proliferation 
rate of bone marrow-derived TN thymocytes in the ab- 
sence of intrathymically expressed SCF. Since TN thymo- 
cytesarerapidlydividingcells(Scollayet al., 1988), amere 
reduction of the proliferation rate by - 50% could account 
for the substantial reduction in the number of TN thymo- 
cytes in the SCF-deficient thymus. 
Since membrane-bound SCF could transduce signals 
into thymic stroma cells following binding of c-M+ thymo- 
cytes to thymic stroma, future analysis of a signaling defec- 
tive SCF mutant (S117n) could provide further insights into 
the interactions of early thymic immigrants and its support- 
ive stroma. 
Experimental Procedures 
Mice 
B6Ly5.2 (Dr. C. Reeder, National Cancer Institute, Frederick, Mary. 
land), C57BU6 SII+ Jackson Laboratories (Bar Harbor, Maine), WB-W/ 
+ (Japan-SLC, Japan), and RAGP-deficient (Dr. F. Alt, The Children’s 
Hospital, Boston, Massachusetts) mice were maintained under spe 
cific pathogen-free conditions. Tissues were isolated from fetal mice 
obtained from timed-pregnant mice. The day of the vaginal plug was 
counted as day 1 of pregnancy. Homozygous mutant mice were identi- 
fied by the pale appearance of fetal liver and skin, by lack of c-kit 
expression on W/W fetal liver cells by flow cytometry, and by lack of 
SCF RNA expression by SllSl fetal liver cells. The SllSl genotype is 
lethal in utero around day 16 of development, while W/W mice have 
a life span of - 10 days after birth (Russell, 1979). 
MAbs 
MAbs used were the following: phycoerythrin (PE)-coupled 5a-6 (anti 
Thy-l, Caltag, San Francisco, California). biotinylated RM2-I (antiCD2, 
Pharmingen, San Diego, California), biotinylated ACK-4 (anti c-kit; 
Ogawa et al., 1991). fluorescein&sothiocynate (FITC)-labeled 145- 
2C11 (anti-CD3; Leo et al., 1967), PE-coupled GK1.5 (anti-CD4; Dial- 
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ynas et al., 1983; Becton Dickinson, Mountain View, California), 
Red613-coupled 53-6.7 (antiCD8; Ledbetter and Herzenberg, 1979; 
GIBCO BRL, Gaithersburg, Maryland), FIT&conjugated 104-2.1 (anti- 
Ly5.1; Shen, 1981) FIT&labeled and biotinylated A20-1.7(anti-Ly5.2; 
Shen, 1961) (both hybridomas provided by Dr. S. Kimura, Sloan- 
Kettering Cancer Center, New York). Second step reagentswerestrep- 
tavidin-PE, streptavidin-FITC (both from Southern Biotechnology As- 
sociates, Birmingham, Alabama) and streptavidin-APC (Molecular 
Probes, Eugene, Oregon). Purified MAbs were biotinylated using NHS- 
LC-biotin (Pierce, Rockford, Illinois) and FITC-labeled using FITC (Iso- 
mer I, Molecular Probes, Eugene, Oregon) following the recommenda- 
tions of the manufacturer. Specific reactivity and optimal antibody 
dilutions were determined by flow cytometry. 
lmmunofluorence Staining, Analysis, and Cell Sorting 
Single cell suspensions were stained with MAbs as indicated in the 
figure legends. All staining and washing steps were made in phos- 
phate-buffered saline (PBS), 5% fetal calf serum. Cells (5 x lo5 to 1 x 
103 were incubated with purified MAbs at 5-10 uglml for 15-36 min 
on ice and washed once. Flow cytofluorometric analysis was per- 
formed on a FACScan (Becton Dickinson, Mountain View, California) 
after gating on viable cells. Fluorescence data are displayed as dot 
plots using LYSYS software (Becton Dickinson). For the analysis of 
BrdU incorporation in vivo, thymus transplants were removed, thy- 
mocytes were stained with MAbs (anti-Ly5.2b*un, CDB-PE, CD4-PE, 
CD8-Red613 followed by streptavidin-APC) and separated into 
Ly5.2’CD3-CD4-CD8- thymocytes using a FACStar cell sorter (Becton 
Dickinson, Mountain View, California). Sorted cell populations were 
reanalyzed for their purity and were found to be > 99% pure. 
Fetal Thymus Transplantations 
Day 14.5 thymic lobes were removed from homozygous mutants (SII 
Sl) and wild-type mice derived from intercrosses of C57BU6 (Sl/+) 
mice. Each individual fetus was phenotyped for expression of SCF 
RNA in fetal liver by reverse PCR (see below). Congenic recipient mice 
(6 weeksold) (B6Ly5.2) were anesthetized with Avertin (2.5% solution, 
10 VI/g body weight) as described (Hogan et al., 1986). A small incision 
(<5 mm) was made in the peritoneal cavity, the left kidney was exposed 
under a stereo microscope, and, using microdissection forceps, two 
thymic lobes from an individual fetus were positioned under the kidney 
capsule. Subsequently, the wound was closed using surgical sutures. 
BrdU Labeling In Vlvo and Detection of BrdU+ Thymocytes by 
Flow Cytometry 
BrdU (Sigma, St. Louis, Missouri) was dissolved in PBS at 4 mglml. 
Mice were injected intraperitoneally with 800 bg BrdU. Mice were killed 
4 hr later and thymus grafts removed from the kidney capsules. Total 
or cell sorter purified thymocytes were permeabilized by addition of 
500 ~170% ethanol in water at room temperature to cell pellets. Cells 
were incubated overnight at 4OC, washed twice with PBS, before addi- 
tion of 500 pl of 3 N HCI, 0.5% Tween. After 20 min the cells were 
pelleted, supernatants removed, and 500 uIO.1 M sodium tetraborate 
was added. Cells were washed twice in PBS, 0.5% Tween and incu- 
bated with 20 nl of FITC-labeled anti-BrdU antibody (Becton Dickin- 
son). Incubation, washes, and cytofluorometric analysis were per- 
formed as described above but without gating on viable cells. 
Unlabeled cells stained with anti-BrdU MAb. and labeled cells without 
staining with anti-BrdU MAb, were used as negative controls. Positive 
and negative cells were clearly separable by the appearance of two 
distinct peaks in histograms. 
Detection of SCF mRNA Expression by Reverse PCR 
Total RNA was isolated from endogenous or transplanted tissues as 
described (Chomczynski and Sacchi, 1987) and reverse transcribed 
into cDNAs using oligo(dT) as primer. cDNAs sewed as templates for 
PCR amplification of SCF or actin DNA using the following pairs of 
oligonucleotides: 5’-GTCAAAACCAAGGAGATCTGCGGG-3’ (sense 
amplimer corresponding to base pairs 82-105) and 5’CTGGCTGC 
AACAGGGGGTAACATe3’(antisense amplimer corresponding to base 
pairs 565-587 in the SCF cDNA according to Zsebo et al. (1990) 
generating a fragment of 508 bp, 5”GGCGGACTGTTACTGAGCT- 
GCG-3’(sense amplimer corresponding to base pairs 1208-1229) and 
5’-AGAAGCAATGCTGTCACCTTCCCC3’(antisense amplimer corre- 
sponding to base pairs 1639-1862 in the actin cDNA), generating a 
fragment of 455 bp. PCR amplification was performed using a PCR 
machine (Techne) with 30 cycles of 94‘C for 1 min, 68oC for 1 min, 
72’C for 0.5 min for SCF, and with 35 cycles of 94OC for 1 min, 60°C 
for 1 min, 72OC for 0.5 min for actin. For Southern blotting, PCR prod- 
ucts were separated on 1.5% agarose gels, transferred onto blotting 
membrane (Biorad, Richmond, California) in 0.4 M NaOH, and probed 
with a =P-labeled internal oligonucleotide (SCF: 5’CTGGTGGCAA 
ATCTTCCAAATG-3’. corresponding to base pairs 122-143) (actin: 
5’-GGTTGGAGCAAACATCCCCC-3’, corresponding to base pairs 
1431-1450). Labeling, hybridizations, and washes were done using 
standard methods (Sambrook et al., 1989). 
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